The term MGC99813 appears to be a gene identifier, potentially from a gene catalog or a specific designation used within a genomic database. Genes in such catalogs are often named with an accession-like format when initially sequenced and before their functions or products are fully characterized. If MGC99813 is indeed a gene, its associated protein product would be the focus for any potential activators. These activators, were they to exist, would be molecules designed to enhance or modulate the activity of the protein encoded by the MGC99813 gene. The mode of action of these activators would depend on the functional domains of the protein and could involve increasing its stability, altering its conformation, or facilitating its interaction with other cellular components or substrates.
In the scenario where MGC99813 Activators were a defined chemical class, a detailed description would include the molecular characteristics that enable specific interaction with the MGC99813 protein. Activators might bind to regions of the protein essential for its activity, potentially inducing a conformational change that results in an increased activity or prevents the protein from being inhibited. The activators might also mimic or enhance the effect of naturally occurring ligands or substrates. Research into such activators would utilize a battery of structural and biochemical techniques to understand the precise nature of the interaction. Techniques like cryo-electron microscopy or X-ray crystallography could be employed to determine the structure of the protein both with and without the activator bound, revealing the binding site and the induced changes in protein structure. Biophysical methods such as surface plasmon resonance or isothermal titration calorimetry would be used to study the binding kinetics and affinity between the protein and the activators. However, in the absence of established research or recognition of MGC99813 Activators in the scientific community, any detailed description of such a class of chemicals remains speculative.
関連項目
Items 1 to 10 of 11 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | ¥1907.00 ¥3373.00 | 66 | |
妥尼霉素会诱发ER应激,从而导致未折叠蛋白反应的激活,有可能影响各种转录物的转录。 | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | ¥1061.00 ¥3937.00 | 114 | |
Thapsigargin 破坏了ER中的钙平衡,导致ER应激,并可能增强某些跨膜蛋白的表达。 | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | ¥338.00 ¥587.00 ¥1376.00 ¥4140.00 | 25 | |
Brefeldin A 会干扰高尔基体的功能,从而引发细胞反应,影响跨膜蛋白的表达。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | ¥733.00 ¥3599.00 ¥6487.00 ¥11259.00 | 28 | |
维甲酸通过其受体发挥作用,调节基因转录,这有可能影响 TMEM198 等转录物的表达。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | ¥857.00 ¥1692.00 ¥8179.00 ¥15626.00 ¥23128.00 | 73 | |
通过提高 cAMP 水平,福斯可林可激活 PKA,从而影响转录物编码基因的转录调控。 | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | ¥733.00 ¥2369.00 | 26 | |
作为一种葡萄糖类似物,2-脱氧-D-葡萄糖可诱导代谢应激,从而改变跨膜蛋白的表达谱。 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | ¥632.00 ¥2933.00 ¥11056.00 | 163 | |
MG-132 是一种蛋白酶体抑制剂,可导致折叠错误蛋白质的积累,从而可能增强参与蛋白稳态的蛋白质(包括跨膜蛋白)的表达。 | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | ¥711.00 ¥1952.00 | 7 | |
氯化钴是一种低氧模拟剂,可以稳定 HIF-1α,导致低氧反应基因的转录激活,其中可能包括转录物。 | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | ¥406.00 ¥767.00 ¥1207.00 ¥2414.00 ¥2640.00 ¥9725.00 ¥22203.00 | 47 | |
姜黄素可以调节各种信号通路并影响转录因子,有可能改变跨膜蛋白的表达。 | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | ¥474.00 ¥812.00 ¥1399.00 ¥2685.00 ¥5867.00 ¥13922.00 | 11 | |
EGCG 是一种多酚,可影响多种细胞通路,并可能调节跨膜蛋白编码基因的表达。 |